Society guideline links: HIV treatment in nonpregnant adults

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Sexually transmitted infections".)

●(See "Society guideline links: Opportunistic infections in individuals with HIV".)

●(See "Society guideline links: Solid organ transplantation in individuals with HIV".)

International

●World Health Organization (WHO): Consolidated guidelines on HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and care for key populations (2022)

●WHO: Consolidated guidelines on HIV prevention, testing, treatment, service delivery, and monitoring – Recommendations for a public health approach, update (2021)

United States

●US Department of Health and Human Services (HHS): Guidelines for the use of antiretroviral agents in adults and adolescents with HIV (2024)

●International Antiviral Society-USA Panel (IAS-USA): Recommendations on antiretroviral drugs for treatment and prevention of HIV infection in adults (2022)

●IAS-USA: Recommendations on drug resistance mutations in HIV-1, update (2022)

●HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA): Primary care guidance for persons with human immunodeficiency virus, 2020 update (published 2021)